GLP1R and acute kidney injury: Mixed population: Two studies (Ghali et al. (2025), Tummala et al. (2025)) [24,26] with 7,902 participants demonstrated a significant increase in acute kidney injury incidence with GLP-1 receptor agonists (RR = 1.37, 95% CI = 1.04-1.80; p = 0.02).